Beigene Ltd ADR (NQ: BGNE )
160.93
+6.19
(+4.00%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
All News about Beigene Ltd ADR
![](https://mms.businesswire.com/media/20221209005054/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU4.jpg)
Will Investors Notice Exciting Sign On BeiGene's Chart?
December 06, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/711264/biontech.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/30/image-workday.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7309.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/706398/gettyimages-1209892070.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/30/image49.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/30/image11.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/14/aapharma_6.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5532.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/23/image-dollar_tree_.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221122005444/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
![](https://mms.businesswire.com/media/20221117005394/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
![](https://mms.businesswire.com/media/20221115005412/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
![](https://mms.businesswire.com/media/20221110005458/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
BeiGene Announces Brazil Approvals for BRUKINSA® As a Treatment for Rare Blood Cancers
November 10, 2022
From BeiGene
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/11/09/shutterstock_1946121031.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221108006299/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
BeiGene Reports Third Quarter 2022 Financial Results
November 09, 2022
From BeiGene, Ltd.
Via Business Wire
![](https://mms.businesswire.com/media/20221104005187/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
BeiGene to Present at Upcoming Investor Conferences
November 04, 2022
From BeiGene
Via Business Wire
![](https://mms.businesswire.com/media/20221103005526/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
![](https://mms.businesswire.com/media/20221102005244/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
![](https://mms.businesswire.com/media/20221026005423/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/19/aapharma_3.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/innovent.jpeg?width=1200&height=800&fit=crop)
![](https://images.pexels.com/photos/2280549/pexels-photo-2280549.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
![](https://mms.businesswire.com/media/20221014005113/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://www.investors.com/wp-content/uploads/2022/10/IT04-BeiGene-05-news.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/12/aapharma_6.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_28050.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
October 13, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.